COMBI 40+ Cochlear Implant System
FDA premarket approval P000025/S113 · decided 2019-10-15
Approval details
- PMA number
- P000025
- Supplement
- S113
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Trade name
- COMBI 40+ Cochlear Implant System
- Generic name
- Implant, cochlear
- Applicant
- Med-El Corp.
- Date received
- 2019-08-16
- Decision date
- 2019-10-15
- Days to decision
- 60 days
- Decision code
- APPR
- Product code
- MCM
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Innsbruck
- Statement
- Approval of the Single-Sided Deafness and Asymmetric Hearing Loss Post-Approval Study protocol.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.